Bon Vivant secures GRAS status for recombinant whey protein

Next-gen Fermentation

Bon Vivant secures GRAS status for recombinant whey protein

Siân Yates

20 January 2025

Bon Vivant secures GRAS status for recombinant whey protein

Bon Vivant, a company specialising in precision fermentation technology, has announced that its recombinant Beta-Lactoglobulin (BLG) whey protein has achieved self-affirmed Generally Recognized as Safe (GRAS) status.

The company has also notified the FDA of this conclusion, enabling it to move forward with commercialisation efforts in the US.

Bon Vivant claims to be the first precision fermentation entity to introduce recombinant BLG in two distinct forms, each designed to provide enhanced techno-functional properties while retaining the nutritional benefits associated with traditional dairy proteins.

The self-affirmed GRAS status is seen as a significant milestone for the company, reinforcing its commitment to safety and innovation in the food sector.

Stéphane Mac Millan, CEO and co-founder of Bon Vivant, said: “Securing the self-affirmed GRAS status is a testament to our commitment to safety, quality and innovation".

"Notifying the FDA of this GRAS conclusion not only reinforces our engagement with US regulatory authorities but also positions Bon Vivant to meet the growing demand for sustainable, functional, high-performance dairy proteins.”

With the GRAS designation, Bon Vivant is now positioned to commercialise its recombinant BLG in the US market, pending a 'No Questions Letter' from the FDA, which is anticipated later in 2025.

The company emphasises sustainability as a core principle of its operations. Bon Vivant's precision fermentation technology reportedly produces high-quality dairy proteins with a significantly reduced environmental impact. A peer-reviewed life cycle assessment indicates that the company’s process achieves a:

72% reduction in greenhouse gas emissions
81% reduction in water consumption
99% reduction in arable land use compared to conventional dairy production.

By offering an alternative to traditional dairy farming, Bon Vivant aims to address critical challenges related to population growth and resource constraints, contributing to a more sustainable food system.

#GRAS #US #BonVivant #precisionfermentation #recombinantprotein

FDA

Clever Carnivore hosts private tastings of cultivated pork in the West Coast

The US Food and Drug Administration (FDA) has issued a 'No Questions' letter to food tech company TurtleTree, confirming the safety of its precision-fermented lactoferrin (LF+) for use in food.

Believer Meats secures US FDA nod for cultivated chicken

Cultivated meat producer Believer Meats has received a green light from the US FDA, confirming the safety of its cell-based chicken and paving the way for future market entry in the US.

USDA approves world’s first cultivated pork and fat products

In a landmark move for the cultivated meat industry, US start-up Mission Barns has become the first company globally to receive full regulatory approval to produce and sell cultivated pork and fat for both retail and foodservice markets.

TurtleTree receives US FDA ‘No Questions’ letter for animal-free lactoferrin

Biotech start-up TurtleTree has received a ‘No Questions’ letter from the US Food and Drug Administration (FDA), validating the safety of...